NFKB1 and cancer: Controversially, as also observed for NFkB- and IFN-mediated signaling pathways, NLRC5 has been reported to exert both pro- and anti-tumorigenic effects in various types of cancer (reviewed by Tang et al. [161]), indicating the need of careful evaluation of upregulation of NLRC5 in cancer.